Literature DB >> 12196569

Unhampered prion neuroinvasion despite impaired fast axonal transport in transgenic mice overexpressing four-repeat tau.

Valerie Künzi1, Markus Glatzel, Michel Y Nakano, Urs F Greber, Fred Van Leuven, Adriano Aguzzi.   

Abstract

Transmissible spongiform encephalopathies often are caused by peripheral uptake of infectious prions, and the peripheral nervous system is involved in prion spread to the brain. Although the cellular prion protein is subjected to fast axonal transport, the mechanism of intranerval transport of infectious prions is unclear. Here we administered prions intranervally to transgenic mice overexpressing the four-repeat human tau protein, which exhibit defective fast axonal transport. These mice showed unaltered neuroinvasion, suggesting that transport mechanisms distinct from fast axonal transport effect prion neuroinvasion along peripheral nerves. Surprisingly, scrapie-sick tau transgenic mice accumulated intraneuronal deposits of hyperphosphorylated tau protein. The coincidence of tau and prion pathology resembled Gerstmann-Sträussler-Scheinker syndrome. These findings identify tau pathology as a possible end stretch of prion-induced neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196569      PMCID: PMC6757970     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  22 in total

1.  Subcellular localization of disease-associated prion protein in the human brain.

Authors:  Gábor G Kovács; Matthias Preusser; Michaela Strohschneider; Herbert Budka
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

2.  Axonal and transynaptic spread of prions.

Authors:  Harold Shearin; Richard A Bessen
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

3.  PrPSc accumulation in neuronal plasma membranes links Notch-1 activation to dendritic degeneration in prion diseases.

Authors:  Stephen J Dearmond; Krystyna Bajsarowicz
Journal:  Mol Neurodegener       Date:  2010-01-21       Impact factor: 14.195

Review 4.  Cellular mechanisms responsible for cell-to-cell spreading of prions.

Authors:  Didier Vilette; Josquin Courte; Jean Michel Peyrin; Laurent Coudert; Laurent Schaeffer; Olivier Andréoletti; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2018-05-14       Impact factor: 9.261

Review 5.  Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease.

Authors:  C-X Gong; K Iqbal
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

6.  Intact microtubules support adenovirus and herpes simplex virus infections.

Authors:  Hélène Mabit; Michel Y Nakano; Ute Prank; Bianca Saam; Katinka Döhner; Beate Sodeik; Urs F Greber
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Phosphorylated human tau associates with mouse prion protein amyloid in scrapie-infected mice but does not increase progression of clinical disease.

Authors:  Brent Race; Katie Phillips; Allison Kraus; Bruce Chesebro
Journal:  Prion       Date:  2016-07-03       Impact factor: 3.931

8.  Ultramicroscopy reveals axonal transport impairments in cortical motor neurons at prion disease.

Authors:  Vladimir Ermolayev; Mike Friedrich; Revaz Nozadze; Toni Cathomen; Michael A Klein; Gregory S Harms; Eckhard Flechsig
Journal:  Biophys J       Date:  2009-04-22       Impact factor: 4.033

9.  Cultured peripheral neuroglial cells are highly permissive to sheep prion infection.

Authors:  Fabienne Archer; Corinne Bachelin; Olivier Andreoletti; Nathalie Besnard; Gregory Perrot; Christelle Langevin; Annick Le Dur; Didier Vilette; Anne Baron-Van Evercooren; Jean-Luc Vilotte; Hubert Laude
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Impaired axonal transport in motor neurons correlates with clinical prion disease.

Authors:  Vladimir Ermolayev; Toni Cathomen; Julia Merk; Mike Friedrich; Wolfgang Härtig; Gregory S Harms; Michael A Klein; Eckhard Flechsig
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.